@misc { , title = {Quantifying and predicting the effect of anti-TNF therapy on axSpA-related fatigue: results from the BSRBR-AS registry and meta-analysis. [Dataset]}, abstract = {Effective management of axial spondyloarthritis (axSpA)-related fatigue is a major unmet clinical need. Anti-TNF therapy may reduce fatigue levels, although any effect has yet to be definitively quantified and predictors of any such improvements are unknown. Anti-TNF therapy results in a significant but modest reduction in fatigue amongst axSpA patients, with those reporting poor sleep quality most likely to report improvement. Effective management will likely require additional approaches. The accompanying file contains supplementary tables and figure.}, doi = {10.1093/rheumatology/keaa132}, note = {INFO COMPLETE (Info added by contact) PERMISSION GRANTED (version = VOR; embargo = 0; licence = BY-NC; SHERPA = https://v2.sherpa.ac.uk/id/publication/1391 ) DOCUMENT READY (chased 12/10/2021 LM; require decision about supp material, VOR downloaded 14/9/2021 LM) ADDITIONAL INFO - Contact: Joanna Shim}, publicationstatus = {Published}, publisher = {Oxford University Press}, url = {https://rgu-repository.worktribe.com/output/1499795}, keyword = {atigue, Anti-tumour necrosis factor, Axial spondylarthritis, Sleep, Registry, Meta-analysis}, year = {2020}, }